Perpetual Ltd
GMAB icon

Perpetual Ltd’s Genmab GMAB Stock Holding History

Perpetual Ltd’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$25.6M Sell
718,179
-200,869
-22% -$6.35M 0.39% 69
2026
Q2 		$25.2M Buy
919,048
+160,545
+21% +$4.27M 0.36% 81
2026
Q1 		$20.4M Sell
758,503
-68,714
-8% -$2.06M 0.31% 83
2025
Q4 		$25.5M Buy
+827,217
New +$25.8M 0.37% 75

Other funds holding GMAB

Oppenheimer Asset Management
Oppenheimer Asset Management New York $9.5B AUM 23.46% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Legacy Wealth Asset Management
Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 31.62% 1-Year Est. Return
Terra Nova Asset Management
Terra Nova Asset Management New York $155M AUM 33.52% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
Atria Investments
Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return
Choreo LLC
Choreo LLC Rockford, Illinois $9.7B AUM 18.43% 1-Year Est. Return
Quadrant Capital Group
Quadrant Capital Group Cincinnati, Ohio $3.7B AUM 33.76% 1-Year Est. Return
Evergreen Capital Management
Evergreen Capital Management Bellevue, Washington $5.65B AUM 21.62% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Perpetual Ltd's GMAB Position: Q3 2026 in Review

Perpetual Ltd reduced its Genmab (GMAB) stake by 22% in Q3 2026, selling an estimated $6.35M and leaving 718,179 shares worth $25.6M. The position accounts for 0.39% of the portfolio, ranked #69.

Perpetual Ltd first reported a position in GMAB in Q4 2025 and has held it in 4 quarters since. 73 funds tracked by Wall St. Rank hold GMAB as of Q3 2026.

  • Perpetual Ltd held 718,179 shares of Genmab worth $25.6M as of Q3 2026.
  • Perpetual Ltd sold 200,869 Genmab shares in Q3 2026, an estimated $6.35M.
  • Genmab made up 0.39% of Perpetual Ltd's portfolio in Q3 2026, its #69 holding.
  • Perpetual Ltd first reported a position in Genmab in Q4 2025 and has held it in 4 quarters since.
  • 73 funds tracked by Wall St. Rank held Genmab as of Q3 2026.

Based on Perpetual Ltd's 13F filing for Q3 2026, filed 13 Oct 2026.